KMT2A and myeloid leukemia: We did not find a significant difference in TERRA levels per transcriptome in MLL-r compared to non-MLL-r myeloid leukemia (p = 0.678) or between non-MLL-r myeloid and lymphoid cell lineage (p = 0.512) (Figure 4C).